Lawrence Nathan Shulman, MD

faculty photo
Professor of Medicine at the Hospital of the University of Pennsylvania
Department: Medicine

Contact information
Abramson Cancer Center
3400 Civic Center Boulevard
Perelman Center for Advanced Medicine
South Pavilion, 12-111
Philadelphia, PA 19104
B.A. (Organic Chemistry)
Syracuse University, 1971.
M.D. (Medicine)
Harvard Medical School, 1975.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

Lawrence N. Shulman, MD, is the Deputy Director for Clinical Services of the Abramson Cancer Center at the University of Pennsylvania, and Director of the Center for Global Cancer Medicine. In this capacity, he helps to lead the Cancer Quality program and strategic development of Cancer Services.

Dr. Shulman is currently Chair of the Commission on Cancer and serves on the National Cancer Policy Forum of the National Academy. He is the former Chair of the American Society of Clinical Oncology Quality of Care Committee and the Commission on Cancer’s Quality Integration Committee. In this regard, Dr. Shulman serves as Senior Oncology Advisor to the non-profit organization Partners In Health (PIH). The PIH mission includes the establishment of national cancer treatment programs with the Ministries of Health in Rwanda and Haiti, programs for which he plays a seminal leadership role. He sits on the Vice Chancellor’s Advisory Council for Rwanda’s University for Global Health Equity. In addition, he helps to lead the development of the national oncology program in Botswana through the Botswana-UPenn Partnership.

Dr. Shulman is a former member of ASCO’s International Affairs Committee and their Task Force on Global Oncology as an Academic Career. He led the World Health Organization’s review and revision of their Essential Medicines for Cancer from 2014-2017.

He received his MD from Harvard Medical School, and trained in Hematology and Oncology at the Beth Israel Hospital in Boston, MA.

Description of Research Expertise

His research includes innovations in cancer care delivery, both in the US and in resource constrained settings, including Rwanda, Botswana and Haiti.

Selected Publications

Manz CR, Parikh RB, Small DS, Evans CN, Chivers C, Regli SH, Hanson CW, Bekelman JE, Rareshide CAL, O'Connor N, Schuchter LM, Shulman LN, Patel MS.: Effect of integrating machine learning mortality estimates with behavioral nudges to clinicians on serious illness conversations among patients with cancer: A stepped-wedge cluster randomized clinical trials. JAMA Oncol Oct 2020.

James TA, Palis B, McCabe R, Pardo JA, Alapati A, Ukandu O, Serres SK, Zhang J, Mele A, Facktor M, Shulman LN. : Evaluating the role of sentinel lymph node biopsy in patients with DCIS treated with breast conserving surgery. Am J Surg 220(3): 654-659, Sept 2020.

Manz CR, Chen J, Liu M, Chivers, Regli SH, Braun J, Draugleis M, Hanson CW, Shulman LN, Schuchter LM, O'Connor N, Bekelman JE, Patel MS, Parikh RB.: Validation of a machine learning algorithm to predict 1890-day mortality for outpatients with cancer. JAMA Oncol Sept 2020.

DeBoer RJ, Fadelu TA, Shulman LN, Van Loon K. : Applying lessons learned from low-resource settings to prioritize cancer care in a pandemic. JAMA Oncol Aug 2020 Notes: online ahead of print.

LeJeune A, Brock JE, Morgan EA, Kasten JL, Martei YM, Fadelu T, Rinder HM, Goulart R, Shulman LN, Milner DA. : Harmonization of the essentials: Matching diagnostics to treatments for global oncology. J Clin Oncol 6: 1352-1356, Aug 2020.

DeBoer RJ, Shyirambere C, Driscoll CD, Butera Y, Paciorek A, Ruhangaza D, Fadelu T, Umwizerwa A, Bigirimana JB, Muhayimana C, Nguyen C, Park PH, Mpunga T, Lehmann L, Shulman LN. : Treatment of Hodgkin lymphoma with ABVD chemotherapy in rural Rwanda: A model for cancer care delivery implementation. JCO Glob Oncol 6, July 2020.

Rubagumya F, Costas-Chavarri A, Manirakiza A, Murenzi G, Uwinkindi F, Ntizimira C, Rukundo I, Mugenzi P, Rugwizangoga B, Shyirambere C, Urusaro S, Pace L, Buswell L, Ntirenganya F, Rudakemwa Em, Fadelu T, Mpunga T, Shulman LN, Booth CM. : State of cancer control in Rwanda: past, present, and future opportunities. JCO Glob Oncol 6: 1171-1177, July 2020.

Takvorian SU, Ladage VP, Wileyto EP, Mace DS, Beidas RS, Shulman LN, Bekelman JE. : Association of behavioral nudges with high-value evidence-based prescribing in oncology. JAMA Oncol 6(7): 1104-1106, Jul 2020.

Dietz JR, Moran MS, Isakoff SJ, Kurtzman SH, Willey SC, Burstein HJ, Bleicher RJ, Lyons JA, Sarantou T, Baron PL, Stevens RE, Boolbol SK, Anderson BO, Shulman LN, Gradishar WJ, Monticciolo DL, Plecha DM, Nelson H, Yao KA. : Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. The COVID-19 pandemic breast consortium. Breast Cancer Res Treat 181(3): 487-497, Jun 2020.

Chua K, Xiong C, Ho C, Mushiroda T, Jiang C, Mulkey F, Lai D, Schneider B, Rashkin S, Witte J, Friedman P, Ratain M, McLeod H, Rugo H, Shulman LN, Kubo M, Owzar K, Kroetz D. : Genomewide meta-analysis identifies a S1PR1 genomic region associated with microtubule targeting agent-induced sensory peripheral neuropathy. Clin Pharmacol Ther June 2020.

back to top
Last updated: 10/22/2020
The Trustees of the University of Pennsylvania